Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI) — Milan

Public research footprint of Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI), compiled from the ClinicalTrials.gov public registry.

150

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Generalized Myasthenia Gravis · Generalized Myasthenia Gravis (gMG) · Chronic Migraine in Children · Niemann-Pick Type C Disease

Recently updated registry entries

NCT07294170 — ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy… (Recruiting)
NCT07082725 — A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… (Recruiting)
NCT07054515 — A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.